DRUG-INDUCED HEPATITIS AND SOME MEDICAL APPROACHES

Download full text PDF
Issue: 
8
Year: 
2017

Professor I. Zverkov, MD Central State Medical Academy, Presidential Administration of the Russian Federation, Moscow

The paper evaluates the efficacy of Silimar in the treatment of patients with drug-induced hepatitis concurrent with cholestastic syndrome, who have received chemotherapy for cancer.
Keywords: 
hepatology
oncology
indicators of cytolysis and cholestasis
clinical manifestations
drug-induced hepatitis
chemotherapy
Silimar

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Lechenie osnovnyh projavlenij boleznej pecheni // Klin. farmakol. i terapija. – 1996; 1: 4–8.
  2. Minushkin O.N. Nekotorye gepatoprotektory v lechenii zabolevanij pecheni // Lechaschij vrach. – 2002; 6: 55–8.
  3. Minushkin O.N., Loginov S.I, Maslovskij L.V. i dr. Vozmozhnost' kliniko-laboratornoj otsenki fibroza pecheni v uslovijah polikliniki // Ter. arh. – 2007; 1: 19–23.
  4. Minushkin O.N., Maslovskij L.V. Lechenie zhirovoj bolezni pecheni razlichnoj etiologii. Rassmotrenie sovremennyh rekomendatsij. // Effektivnaja farmakoterapija (gastroenterologija). – 2012; 3: 14–20.
  5. Maev I.V., Samsonov A.A, Andreev D.N. Bolezni zheludka / M., 2015; s. 15–24.
  6. Pasechnikov V.D., Chukov S.Z., Kotelevets S.M. Profilaktika raka zheludka na osnove eradikatsionnoj terapii predopuholevyh zabolevanij // Ros. zhurn. gastroenterol., gepatol., koloproktol. – 2003; 4: 11–9.